Skip to main content
INMD
NASDAQ Industrial Applications And Services

InMode Q3 Revenue $92.1M, Reaffirms 2026 Outlook as Special Committee Winds Down

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$13.63
Mkt Cap
$790.081M
52W Low
$12.72
52W High
$16.67
52W Position info
7.2% above low
Off High info
18% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

INMD is trading near its 52-week low of $12.72 (7.2% above the low) on elevated volume (1.9× avg).

Summary

InMode posted $92.1M in Q3 revenue, reaffirmed its full-year 2026 outlook, and disclosed that the Special Committee reviewing the expired take-private bid has ceased activities as it resumes investor outreach.


Key Events · Earnings and Guidance · INMD

  • Q3 Revenue at Top of Guided Range

    GAAP revenue of $92.1M versus $93.2M a year earlier, at the high end of the $91.8M-$92M range guided on October 13. Consumables and service revenue fell 3% to $19.3M.

  • Special Committee Disbands, IR Restarts

    The Special Committee reviewing the unsolicited take-private proposal, which expired September 15, 2026, has completed its work and ceased activities. InMode will resume investor conferences and analyst engagement and plans a Q4/full-year earnings call early next year.

  • Full-Year 2026 Outlook Reaffirmed

    Management reiterated revenue of $365M-$375M, non-GAAP operating income of $68M-$73M and non-GAAP diluted EPS of $1.29-$1.34.

  • Operating Margin Compresses to 19%

    GAAP operating income fell to $17.5M from $20.9M as sales and marketing rose to $46.0M and G&A to $4.5M; management expects these expense pressures to continue.


Analysis · INMD · Industrial Applications And Services

Revenue landed at the top of the guided range, but the bigger news is governance: the Special Committee reviewing the expired $16.20-per-share take-private proposal has finished and disbanded, and InMode is restarting investor relations and analyst engagement. That closes the strategic-alternatives chapter opened by the September 15 expiry, leaving the company standalone with a reaffirmed $365M-$375M revenue outlook. The offset is margin: GAAP operating margin fell to 19% from 22% on a restructured North American sales team and higher professional fees, and management says those costs persist. With $512.7M of cash against a roughly $790M market cap, the equity is largely cash-backed, so the operating expense trend is what drives the valuation from here.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INMD was trading at $13.63 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $790.1M. The 52-week trading range was $12.72 to $16.67. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INMD - Latest Insights

INMD
Nov 11, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.34
Real-time Price: $13.19 info
Change: -$0.150 (-1%) info
Market Cap: $759.008M info
INMD
Oct 26, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $13.97
Real-time Price: $13.19 info
Change: -$0.780 (-6%) info
Market Cap: $759.008M info
INMD
Oct 13, 2026, 7:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $14.30
Real-time Price: $13.19 info
Change: -$1.11 (-8%) info
Market Cap: $759.008M info
INMD
Aug 11, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.14
Real-time Price: $13.19 info
Change: -$1.95 (-13%) info
Market Cap: $759.008M info
INMD
Aug 05, 2026, 6:09 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $15.37
Real-time Price: $13.19 info
Change: -$2.18 (-14%) info
Market Cap: $759.008M info